We are live on ! Find out more
CA

Callahan Advisors Portfolio holdings

AUM $1.33B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+12.43%
1 Year Est. Return
+29.71%
3 Year Est. Return
+87.75%
5 Year Est. Return
+121.89%
10 Year Est. Return
+408.77%
AUM
$891M
AUM Growth
+$97.8M
Cap. Flow
+$10.2M
Cap. Flow %
1.14%
Top 10 Hldgs %
29.98%
Holding
153
New
7
Increased
75
Reduced
46
Closed
5

Top Buys

Rank Stock Value
1
DHI icon
D.R. Horton
DHI
+$2.2M
2
PARA
Paramount Global Class B
PARA
+$1.85M
3
PFE icon
Pfizer
PFE
+$1.84M
4
FDX icon
FedEx
FDX
+$1.32M
5
EXP icon
Eagle Materials
EXP
+$1.25M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.75M
2
T icon
AT&T
T
+$1.67M
3
FTNT icon
Fortinet
FTNT
+$1.51M
4
BUD
ANHEUSER BUSCH COS INC
BUD
+$1.33M
5
FICO icon
Fair Isaac
FICO
+$1.05M

Sector Composition

Rank Sector Weight
1 Technology 18.55%
2 Healthcare 16.63%
3 Consumer Discretionary 11.81%
4 Financials 10.81%
5 Communication Services 9.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QTEC icon
151
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.63B
– –
-1,275
Closed -$201K
TEN
152
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
– –
-12,500
Closed -$178K
BUD
153
DELISTED
ANHEUSER BUSCH COS INC
BUD
– –
-23,590
Closed -$1.33M
3 4 5 6
7

Similar funds

SWM
SHP Wealth Management Plymouth, Massachusetts $1.33B AUM
MRL
Mantle Ridge LP New York $1.33B AUM 11.36% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return
CRAM
Compass Rose Asset Management New York $1.33B AUM 2.38% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
MDSL
M.D. Sass LLC New York $1.32B AUM 16.01% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Callahan Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Callahan Advisors held 153 positions worth $891M, up 12% from $794M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Callahan Advisors's Q4 2021 filing shows 7 new, 75 increased, 46 reduced and 5 closed positions. Its largest new stake was Paramount Global Class B: 53,775 shares worth $1.62M. The largest sale was Bristol-Myers Squibb, an estimated $1.75M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Callahan Advisors's largest Q4 2021 buy was Paramount Global Class B: 53,775 shares worth $1.62M.
  • Callahan Advisors added most to D.R. Horton in Q4 2021, an estimated $2.2M increase.
  • Callahan Advisors's biggest Q4 2021 reduction was Bristol-Myers Squibb, cutting an estimated $1.75M.
  • Callahan Advisors fully exited ANHEUSER BUSCH COS INC in Q4 2021, selling an estimated $1.33M.
  • Callahan Advisors's ten largest holdings make up 30% of its $891M portfolio in Q4 2021.
  • Callahan Advisors opened 7 new positions and closed 5 in Q4 2021.
  • Callahan Advisors's portfolio value rose 12% quarter-over-quarter to $891M.

Based on Callahan Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.